BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Norwood Immunology Limited Announces The Appointment Of Rolf Stahel As Non-Executive Chairman


10/19/2005 5:11:28 PM

Norwood Abbey Limited, (OTC:NABYY)(OTC:NABYF)(ASX:NAL), an immunology therapy company focused on technology to rejuvenate the immune system, announces the intention to appoint Mr. Rolf Stahel, the former Chief Executive of Shire Pharmaceuticals, as Non-Executive Chairman, on admission of the Company's shares to the AIM Market of the London Stock Exchange. Simultaneous to this announcement, Norwood Immunology has confirmed that its Pathfinder Admission Document for its AIM flotation will be released today. Mr. Stahel, 60, has approximately 37 years' experience in the healthcare industry, including at board level in his role as Chief Executive of Shire Pharmaceuticals Group plc ("Shire"). Prior to his role at Shire, Mr. Stahel worked for 27 years with Wellcome plc in Switzerland, Italy, Thailand, Singapore and the UK. His last position with Wellcome plc was Director of Group Marketing, responsible for group strategy, research and development evaluation, marketing of existing and new products and business development.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->